UNC Lineberger researchers shared research findings and expertise Oct. 18-21 at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
CHAPEL HILL — UNC Lineberger Comprehensive Cancer Center radiation oncology researchers presented research findings and expertise at the American Society for Radiation Oncology annual meeting, held in San Antonio Oct. 18-21. The meeting was expected to draw more than 11,000 attendees to San Antonio.
“UNC Lineberger researchers are making important contributions to improve the practice of radiation oncology through our experience and research, and this was exemplified by our strong presence at the ASTRO Annual Meeting, the premier conference in our field,” said Lawrence Marks, MD, a UNC Lineberger member, the Dr. Sidney K. Simon Distinguished Professor of Oncology Research, and chairman of the UNC School of Medicine Department of Radiation Oncology. “I am most proud of all of the good work that we are doing, and of our terrific team that helps to support all of our efforts.”
Researchers presented research findings in oral sessions and poster presentations. Also, Joel Tepper, MD, PhD, a UNC Lineberger member and Hector MacLean Distinguished Professor of Cancer Research in Radiation Oncology, was a scientific discussant in a gastrointestinal cancer discussion session and was also a moderator of several other sessions. Bhishamjit S. Chera, MD, a UNC Lineberger member, an associate professor in the UNC School of Medicine Department of Radiation Oncology, presented findings from a study he led on treatment for HPV-positive head and neck cancer patients during the meeting press program.
Other highlights from the meeting include:
- Jahan Mohiuddin and co-authors presented findings from the study “Effectiveness of Neoadjuvant Chemotherapy in Reducing Mastectomy for Women With Breast Cancer: Analysis of a Large National Database” during a poster session for research on breast cancer.
- Cameron Bloomquist, lead author of the study “A Continuous 3D-Printing Technique for Rapid Fabrication of Personalized Compensator Devices,” presented findings in an oral session.
- Aaron Falchook and co-authors presented findings from the study “Factors Associated With Discordance Between Patient and Physician Reported Toxicity During Radiation Therapy for Head and Neck Cancer” during an oral session on patient-reported outcomes.
- Falchook also presented findings from the study “Trends in Androgen Deprivation Therapy Use With Radiation for Intermediate- and High-Risk Prostate Cancer Across the United States” in an oral session.
- Xi Tian and co-authors presented findings from “CRLX101, an Investigational Nanoparticle Drug Conjugate of Camptothecin, as a Potentially Effective Radiosensitizer in Chemoradiation Treatment of Colorectal Cancer” in an oral session on radio-sensitizers.
- Findings led by Brock Baker and co-authors from the study “Changes in Radiation Therapy Modalities Used Across the United States for Prostate Cancer From 2004 to 2012″ were presented in a poster viewing.
- Baker and co-authors also presented findings from “Association Between Socioeconomic Status (SES) Variables and Outcomes Using Registry Data: Is Regional or Individual SES More Important?” in a poster session.
- Michael Dance and co-authors presented findings from “Quality Comparison of Head and Neck Intensity Modulated Radiation Therapy Plans on a Prospective Multi-institutional Clinical Trial: Tomotherapy Versus IMRT Matched to a Low Anterior Neck Field.”
- Jordan Holmes and co-authors presented “Quality of Care Received in a Population-Based Prospective Prostate Cancer Cohort Using National Consensus Indicators” in a poster session.
- Panayiotis Mavroidis and co-authors presented findings from “Dose Response Relations for Xerostomia from Head and Neck Cancer Radiation Therapy” in a poster session.
- Timothy Zagar and co-authors presented findings from “Prospective Assessment of Deep Inspiration Breath Hold to Prevent Radiation Associated Cardiac Perfusion Defects in Patients With Left-Sided Breast Cancer” in a poster session.
- Michael Eblan presented preliminary findings from the study “Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy: A Pilot Study.”